These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 29602698)

  • 1. Novel insights into the functional metabolic impact of an apparent de novo m.8993T>G variant in the MT-ATP6 gene associated with maternally inherited form of Leigh Syndrome.
    Uittenbogaard M; Brantner CA; Fang Z; Wong LC; Gropman A; Chiaramello A
    Mol Genet Metab; 2018 May; 124(1):71-81. PubMed ID: 29602698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The nuclear background influences the penetrance of the near-homoplasmic m.1630 A > G MELAS variant in a symptomatic proband and asymptomatic mother.
    Uittenbogaard M; Wang H; Zhang VW; Wong LJ; Brantner CA; Gropman A; Chiaramello A
    Mol Genet Metab; 2019 Apr; 126(4):429-438. PubMed ID: 30709774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole mitochondrial genome analysis of a family with NARP/MILS caused by m.8993T>C mutation in the MT-ATP6 gene.
    Kara B; Arıkan M; Maraş H; Abacı N; Cakıris A; Ustek D
    Mol Genet Metab; 2012 Nov; 107(3):389-93. PubMed ID: 22819295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of four iPSC lines from four patients with Leigh syndrome carrying homoplasmic mutations m.8993T > G or m.8993T > C in the mitochondrial gene MT-ATP6.
    Lorenz C; Zink A; Henke MT; Staege S; Mlody B; Bünning M; Wanker E; Diecke S; Schuelke M; Prigione A
    Stem Cell Res; 2022 May; 61():102742. PubMed ID: 35279592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The m.11778 A > G variant associated with the coexistence of Leber's hereditary optic neuropathy and multiple sclerosis-like illness dysregulates the metabolic interplay between mitochondrial oxidative phosphorylation and glycolysis.
    Uittenbogaard M; Brantner CA; Fang Z; Wong LJ; Gropman A; Chiaramello A
    Mitochondrion; 2019 May; 46():187-194. PubMed ID: 29890302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epilepsy in MT-ATP6 - related mils/NARP: correlation of elettroclinical features with heteroplasmy.
    Licchetta L; Ferri L; La Morgia C; Zenesini C; Caporali L; Lucia Valentino M; Minardi R; Fulitano D; Di Vito L; Mostacci B; Alvisi L; Avoni P; Liguori R; Tinuper P; Bisulli F; Carelli V
    Ann Clin Transl Neurol; 2021 Mar; 8(3):704-710. PubMed ID: 33476484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical consequences in yeast of the human mitochondrial DNA 8993T>C mutation in the ATPase6 gene found in NARP/MILS patients.
    Kucharczyk R; Rak M; di Rago JP
    Biochim Biophys Acta; 2009 May; 1793(5):817-24. PubMed ID: 19269308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human NARP mitochondrial mutation metabolism corrected with alpha-ketoglutarate/aspartate: a potential new therapy.
    Sgarbi G; Casalena GA; Baracca A; Lenaz G; DiMauro S; Solaini G
    Arch Neurol; 2009 Aug; 66(8):951-7. PubMed ID: 19667215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel MT-ATP6 variant associated with complicated ataxia in two unrelated Italian patients: case report and functional studies.
    Sala D; Marchet S; Nanetti L; Legati A; Mariotti C; Lamantea E; Ghezzi D; Catania A; Lamperti C
    Orphanet J Rare Dis; 2024 May; 19(1):200. PubMed ID: 38755691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deregulating mitochondrial metabolite and ion transport has beneficial effects in yeast and human cellular models for NARP syndrome.
    Su X; Rak M; Tetaud E; Godard F; Sardin E; Bouhier M; Gombeau K; Caetano-Anollés D; Salin B; Chen H; di Rago JP; Tribouillard-Tanvier D
    Hum Mol Genet; 2019 Nov; 28(22):3792-3804. PubMed ID: 31276579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Episodic weakness due to mitochondrial DNA MT-ATP6/8 mutations.
    Auré K; Dubourg O; Jardel C; Clarysse L; Sternberg D; Fournier E; Laforêt P; Streichenberger N; Petiot P; Gervais-Bernard H; Vial C; Bedat-Millet AL; Drouin-Garraud V; Bouillaud F; Vandier C; Fontaine B; Lombès A
    Neurology; 2013 Nov; 81(21):1810-8. PubMed ID: 24153443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allotopic mRNA localization to the mitochondrial surface rescues respiratory chain defects in fibroblasts harboring mitochondrial DNA mutations affecting complex I or v subunits.
    Bonnet C; Kaltimbacher V; Ellouze S; Augustin S; Bénit P; Forster V; Rustin P; Sahel JA; Corral-Debrinski M
    Rejuvenation Res; 2007 Jun; 10(2):127-44. PubMed ID: 17518546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective diagnosis of MT-ATP6-related mitochondrial disease by newborn screening.
    Peretz RH; Ah Mew N; Vernon HJ; Ganetzky RD
    Mol Genet Metab; 2021; 134(1-2):37-42. PubMed ID: 34176718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diversities in Leigh Syndrome Associated with MT-ATP6 Gene Variants.
    Martins S; Santos MJ; Simões M; Jacinto S; Martins Halpern C; Dupont J; Diogo L; Grazina M
    Endocr Metab Immune Disord Drug Targets; 2023 Oct; ():. PubMed ID: 37817524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of two mother-child pairs of iPSCs from maternally inherited Leigh syndrome patients with m.8993 T > G and m.9176 T > G MT-ATP6 mutations.
    Henke MT; Zink A; Diecke S; Prigione A; Schuelke M
    Stem Cell Res; 2023 Mar; 67():103030. PubMed ID: 36669241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early infantile-onset Leigh syndrome complicated with infantile spasms associated with the m.9185 T > C variant in the MT-ATP6 gene: Expanding the clinical spectrum.
    Takada R; Tozawa T; Kondo H; Kizaki Z; Kishita Y; Okazaki Y; Murayama K; Ohtake A; Chiyonobu T
    Brain Dev; 2020 Jan; 42(1):69-72. PubMed ID: 31500933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotype-phenotype analysis of MT-ATP6-associated Leigh syndrome.
    Na JH; Lee YM
    Acta Neurol Scand; 2022 Apr; 145(4):414-422. PubMed ID: 34877647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial DNA background modifies the bioenergetics of NARP/MILS ATP6 mutant cells.
    D'Aurelio M; Vives-Bauza C; Davidson MM; Manfredi G
    Hum Mol Genet; 2010 Jan; 19(2):374-86. PubMed ID: 19875463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the Bioenergetics Health Index Ratio in Leigh Syndrome Fibroblasts to Understand Disease Severity.
    Bakare AB; Dean J; Chen Q; Thorat V; Huang Y; LaFramboise T; Lesnefsky EJ; Iyer S
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MT-ATP6 mitochondrial disease variants: Phenotypic and biochemical features analysis in 218 published cases and cohort of 14 new cases.
    Ganetzky RD; Stendel C; McCormick EM; Zolkipli-Cunningham Z; Goldstein AC; Klopstock T; Falk MJ
    Hum Mutat; 2019 May; 40(5):499-515. PubMed ID: 30763462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.